Post Marketing Study of Safety and Efficacy of Crystalys, a Calcium Hydroxyapatite Based Filler for Facial Soft Tissue Augmentation
In this post marketing study our primary objective was to assess the safety of Crystalys, a new calcium hydroxyapatite based filler, in subjects who received sub-dermal or deep-dermal injections for facial soft tissue augmentation. The secondary objective was to evaluate the performance of Crystalys within six months of injection.
Fat tissue in energy saving mode
Scientists at the Max Planck Institute for Metabolism Research in Cologne have discovered brain cells, which not only tell hungry mice to search for food, but also to limit blood sugar use by the brown fat tissue. This could ensure the survival of mice when they cannot find enough to eat. What happens when […]
– Net Sales +2.7%, benefiting from contribution of new businesses – Growth driven by Dermatology +13.3%, which now accounts for 43% of sales vs. 39% in Q1 15 – Product mix drove Gross Margin improvement of +40bps – Integration of new businesses on track – R&D pipeline continues to progress: 3 Phase III programs – […]
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This milestone is a strong reflection of Merck’s progress in biosimilars, with the goal of delivering high-quality biologics to patients all over the world. “With the […]